We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You can change your cookie settings at any time.
Find information and services
Search for a department and find out what the government is doing
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency is calling for women who experience symptoms associated with overactive bladder such as the urgent need to urinate to make their views heard as part of a consultation l…
Use of the Moderna COVID-19 vaccine or ‘Spikevax’ has been approved for 6 to 11s after meeting the required safety, quality and effectiveness standards
An approval has been granted after the Valneva COVID-19 vaccine was found to meet the required safety, quality and effectiveness standards.
Stakeholders and the UK public are invited to have their say on how the Medicines and Healthcare products Regulatory Agency (MHRA) manages the conflicts of interest for independent experts and how patients can be more involv…
The decision to grant approval for this treatment was endorsed by the government’s independent expert scientific advisory body, the Commission on Human Medicines, after carefully reviewing the evidence.
The MHRA, NIHR, HRA and other organisations across the UK are working together to bring about changes which will drive up standards in health and social care research.
Syri Ltd has been fined £51,000 and ordered to pay costs of £104,898 by Aylesbury Crown Court.
A reflection by Dr June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency
The vaccine has been approved after meeting the required safety, quality and effectiveness standards.
The MHRA has launched a public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
Significant clarification of the life-changing EAMS scheme to be introduced into law.
People are encouraged to contribute their views on far-reaching proposed revisions to the clinical trial legislation in the UK
A statement from Dame June Raine DBE on being recognised in the 2022 New Year Honours List
This new combination treatment is for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19
The Medicines and Healthcare products Regulatory Agency has today issued a recall asking patients to return affected products.
A new paediatric formulation of the Pfizer BioNTech COVID-19 vaccine has been approved for children aged 5 to 11 after meeting the required safety, quality and effectiveness standards.
This new guidance follows consultation with stakeholders from the pharmaceutical industry, academic research, trade associations, patient organisations/charities, healthcare providers and regulatory organisations.
A statement on the temporary waiver of 15-minute observation period after COVID-19 mRNA vaccines
This monoclonal antibody – the second to be authorised by the Medicines and Healthcare products Regulatory Agency – is for people with mild to moderate COVID-19 who are at high risk of developing severe disease.
As a precaution, companies are recalling some batches of irbesartan medicines due to presence of a chemical substance (AZBT) in an amount over the limit permitted for this product. Patients taking irbesartan medicines should…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.